Amgen Inc. (AMGN) Q1 2018 Earnings Results

Amgen Beats on EPS, Stock Down 1.56%

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.56%, likely due to the lack of revenue details and guidance. Investors may be cautious as they await more information on future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.47	N/A	+6.61%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook on operational performance. However, they did not provide specific guidance for future quarters.

Management highlighted strong performance in key therapeutic areas.

They expressed confidence in ongoing product pipelines.

Amgen Beats on EPS, Stock Down 1.56%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 1.56%

Key numbers

Management commentary